These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


532 related items for PubMed ID: 12130497

  • 1. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
    Hess DA, Levac KD, Karanu FN, Rosu-Myles M, White MJ, Gallacher L, Murdoch B, Keeney M, Ottowski P, Foley R, Chin-Yee I, Bhatia M.
    Blood; 2002 Aug 01; 100(3):869-78. PubMed ID: 12130497
    [Abstract] [Full Text] [Related]

  • 2. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM, Tafuri A, Fortuna A, Petrucci MT, Ricciardi MR, Catani L, Rondelli D, Fogli M, Leopardi G, Ariola C, Tura S.
    Blood; 1997 Feb 15; 89(4):1189-96. PubMed ID: 9028941
    [Abstract] [Full Text] [Related]

  • 3. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
    Donahue RE, Kirby MR, Metzger ME, Agricola BA, Sellers SE, Cullis HM.
    Blood; 1996 Feb 15; 87(4):1644-53. PubMed ID: 8608259
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F, Stroncek D, Verfaillie CM.
    Blood; 1996 Sep 15; 88(6):2033-42. PubMed ID: 8822922
    [Abstract] [Full Text] [Related]

  • 5. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G.
    Exp Hematol; 1999 Mar 15; 27(3):416-24. PubMed ID: 10089903
    [Abstract] [Full Text] [Related]

  • 6. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
    Murray L, Chen B, Galy A, Chen S, Tushinski R, Uchida N, Negrin R, Tricot G, Jagannath S, Vesole D.
    Blood; 1995 Jan 15; 85(2):368-78. PubMed ID: 7529060
    [Abstract] [Full Text] [Related]

  • 7. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 15; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.
    Blood; 1994 Nov 01; 84(9):2930-9. PubMed ID: 7524760
    [Abstract] [Full Text] [Related]

  • 9. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar 01; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 10. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.
    van der Loo JC, Hanenberg H, Cooper RJ, Luo FY, Lazaridis EN, Williams DA.
    Blood; 1998 Oct 01; 92(7):2556-70. PubMed ID: 9746798
    [Abstract] [Full Text] [Related]

  • 11. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
    Hess DA, Bonde J, Craft TP, Wirthlin L, Hohm S, Lahey R, Todt LM, Dipersio JF, Devine SM, Nolta JA.
    Biol Blood Marrow Transplant; 2007 Apr 01; 13(4):398-411. PubMed ID: 17382247
    [Abstract] [Full Text] [Related]

  • 12. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor.
    Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM.
    Proc Natl Acad Sci U S A; 1996 Oct 15; 93(21):11871-6. PubMed ID: 8876230
    [Abstract] [Full Text] [Related]

  • 13. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W, Möcklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L.
    Blood; 1993 May 15; 81(10):2579-84. PubMed ID: 7683923
    [Abstract] [Full Text] [Related]

  • 14. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D, Gross A, Kosova N, Fichtner I, Salama A.
    Transfusion; 2005 Jul 15; 45(7):1192-200. PubMed ID: 15987366
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G, Zeis M, Glass B, Dreger P, Steinmann J, Schmitz N, Uharek L.
    Bone Marrow Transplant; 2003 Jul 15; 32(1):49-56. PubMed ID: 12815478
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N, Ishikawa R, Inoue H, Nishikawa M, Kakeda M, Yoneya T, Tsumura H, Ohashi H, Yamaguchi Y, Motoki K, Sudo T, Mori KJ.
    Exp Hematol; 1996 Sep 15; 24(11):1312-21. PubMed ID: 8862442
    [Abstract] [Full Text] [Related]

  • 17. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P, Caballero MD, Prosper F, Del Cañizo MC, Pérez-Simón JA, Mateos MV, Nieto MJ, Corral M, Romero M, García-Conde J, Montalbán MA, San Miguel JF, Orfao A.
    Transfusion; 2002 Sep 15; 42(9):1159-72. PubMed ID: 12430673
    [Abstract] [Full Text] [Related]

  • 18. Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver.
    Muench MO, Roncarolo MG, Rosnet O, Birnbaum D, Namikawa R.
    Exp Hematol; 1997 Apr 15; 25(4):277-87. PubMed ID: 9131001
    [Abstract] [Full Text] [Related]

  • 19. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
    Prosper F, Vanoverbeke K, Stroncek D, Verfaillie CM.
    Blood; 1997 Jun 01; 89(11):3991-7. PubMed ID: 9166837
    [Abstract] [Full Text] [Related]

  • 20. HIF-1α-stabilizing agent FG-4497 rescues human CD34+ cell mobilization in response to G-CSF in immunodeficient mice.
    Nowlan B, Futrega K, Brunck ME, Walkinshaw G, Flippin LE, Doran MR, Levesque JP.
    Exp Hematol; 2017 Aug 01; 52():50-55.e6. PubMed ID: 28527810
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.